Global Self-injectable Biologics Market Research Report 2026(Status and Outlook)

May 2026 | 166 pages | ID: GBBCA71C2C41EN
Bosson Research

Abstracts

Self-injectable biologics refer to biologic drugs that patients can administer independently without direct supervision from healthcare professionals. These therapies are commonly applied in chronic disease management, including diabetes, obesity, autoimmune disorders, and specific metabolic conditions. The defining feature is the combination of high-molecular biologics—such as recombinant proteins, monoclonal antibodies, and GLP-1 receptor agonists—with user-friendly injection devices, including prefilled pens, autoinjectors, microneedle patches, and wearable pumps, enabling safe, precise, and adherence-oriented administration at home. With ongoing advances in injection technology and biologic stabilization, self-injectable biologics are increasingly central to chronic care and personalized medicine.The average gross profit margin of this product is 65%.The growth of the self-injectable biologics market is driven by the rising prevalence of chronic diseases and strong patient demand for convenient home-based therapy. Advances in technology have enabled the development of smart injection devices and wearable delivery systems, offering precise, safe administration while improving adherence and treatment outcomes. Integration of digital health tools, such as remote monitoring and dose tracking, further promotes adoption. Additionally, the shift from hospital-centric care to community- and home-based management creates expanded market penetration opportunities for self-injectable biologics.Despite strong market potential, self-injectable biologics face multiple challenges. Stability, storage conditions, and long-term safety are core technical risks, while patient competence and adherence in device use remain key constraints. High production costs, cold-chain logistics, and inconsistent reimbursement policies across regions may limit market penetration. Regulatory variations and uncertain approval pathways for combination drug-device products add commercialization risk, and emerging biologics and small-molecule immunomodulators may exert competitive pressure on market share.Downstream demand is shifting from institution-centered to patient-centered care. Patients increasingly prefer user-friendly, minimally painful, long-acting, and smart self-injection devices to improve chronic disease management. Diabetes, obesity, rheumatologic autoimmune disorders, and rare metabolic diseases are primary applications. Integration with digital health monitoring enables adherence tracking, dose optimization, and remote management as new standards. Patient focus on long-term tolerability and cost-effectiveness is further driving the trend toward personalized, home-based therapy.Key upstream materials for self-injectable biologics include high-purity protein actives, stabilizing excipients such as polysaccharides and buffered systems, medical-grade polymers, and injection device components (e.g., polypropylene, polycarbonate, thermoplastic elastomers). Purification and lyophilization processes determine drug stability, while biocompatibility and barrier properties of carrier materials affect preservation and delivery efficiency. With increasing adoption of microneedle patches, wearable pumps, and nanocarrier systems, microfluidic components and aseptic coatings have become essential upstream innovations. Green chemistry and continuous synthesis techniques are driving upstream production toward greater efficiency, safety, and sustainability.

The global Self-injectable Biologics market size was estimated at USD 98671.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Self-injectable Biologics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Self-injectable Biologics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Self-injectable Biologics market.

Global Self-injectable Biologics Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Novo Nordisk
• Sanofi-Aventis
• Eli Lilly
• Tonghua Dongbao
• United Laboratory
• Biocon
• GSK
• Bristol-Myers Squibb
• Ganlee
• Julphar Diabetes
• Wockhardt
• Viatris
• BD
• Johnson & Johnson
• Amgen
• Biogen Idec
• Bayer
• Pfizer
• Roche
• AbbVie
• Takeda Pharmaceutical

Market Segmentation (by Type)

• Insulin
• GLP-1 Receptor Agonists
• rhGH
• Subcutaneous mAbs
• Other

Market Segmentation (by Application)

• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Self-injectable Biologics Market

Overview of the regional outlook of the Self-injectable Biologics Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Self-injectable Biologics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Self-injectable Biologics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Self-injectable Biologics
1.2 Key Market Segments
  1.2.1 Self-injectable Biologics Segment by Type
  1.2.2 Self-injectable Biologics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SELF-INJECTABLE BIOLOGICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Self-injectable Biologics Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Self-injectable Biologics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SELF-INJECTABLE BIOLOGICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Self-injectable Biologics Product Life Cycle
3.3 Global Self-injectable Biologics Sales by Manufacturers (2020-2025)
3.4 Global Self-injectable Biologics Revenue Market Share by Manufacturers (2020-2025)
3.5 Self-injectable Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Self-injectable Biologics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Self-injectable Biologics Market Competitive Situation and Trends
  3.8.1 Self-injectable Biologics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Self-injectable Biologics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SELF-INJECTABLE BIOLOGICS INDUSTRY CHAIN ANALYSIS

4.1 Self-injectable Biologics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SELF-INJECTABLE BIOLOGICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Self-injectable Biologics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Self-injectable Biologics Market
5.7 ESG Ratings of Leading Companies

6 SELF-INJECTABLE BIOLOGICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Self-injectable Biologics Sales Market Share by Type (2020-2025)
6.3 Global Self-injectable Biologics Market Size by Type (2020-2025)
6.4 Global Self-injectable Biologics Price by Type (2020-2025)

7 SELF-INJECTABLE BIOLOGICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Self-injectable Biologics Market Sales by Application (2020-2025)
7.3 Global Self-injectable Biologics Market Size (M USD) by Application (2020-2025)
7.4 Global Self-injectable Biologics Sales Growth Rate by Application (2020-2025)

8 SELF-INJECTABLE BIOLOGICS MARKET SALES BY REGION

8.1 Global Self-injectable Biologics Sales by Region
  8.1.1 Global Self-injectable Biologics Sales by Region
  8.1.2 Global Self-injectable Biologics Sales Market Share by Region
8.2 Global Self-injectable Biologics Market Size by Region
  8.2.1 Global Self-injectable Biologics Market Size by Region
  8.2.2 Global Self-injectable Biologics Market Size by Region
8.3 North America
  8.3.1 North America Self-injectable Biologics Sales by Country
  8.3.2 North America Self-injectable Biologics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Self-injectable Biologics Sales by Country
  8.4.2 Europe Self-injectable Biologics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Self-injectable Biologics Sales by Region
  8.5.2 Asia Pacific Self-injectable Biologics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Self-injectable Biologics Sales by Country
  8.6.2 South America Self-injectable Biologics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Self-injectable Biologics Sales by Region
  8.7.2 Middle East and Africa Self-injectable Biologics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SELF-INJECTABLE BIOLOGICS MARKET PRODUCTION BY REGION

9.1 Global Production of Self-injectable Biologics by Region(2020-2025)
9.2 Global Self-injectable Biologics Revenue Market Share by Region (2020-2025)
9.3 Global Self-injectable Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Self-injectable Biologics Production
  9.4.1 North America Self-injectable Biologics Production Growth Rate (2020-2025)
  9.4.2 North America Self-injectable Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Self-injectable Biologics Production
  9.5.1 Europe Self-injectable Biologics Production Growth Rate (2020-2025)
  9.5.2 Europe Self-injectable Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Self-injectable Biologics Production (2020-2025)
  9.6.1 Japan Self-injectable Biologics Production Growth Rate (2020-2025)
  9.6.2 Japan Self-injectable Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Self-injectable Biologics Production (2020-2025)
  9.7.1 China Self-injectable Biologics Production Growth Rate (2020-2025)
  9.7.2 China Self-injectable Biologics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Novo Nordisk
  10.1.1 Novo Nordisk Basic Information
  10.1.2 Novo Nordisk Self-injectable Biologics Product Overview
  10.1.3 Novo Nordisk Self-injectable Biologics Product Market Performance
  10.1.4 Novo Nordisk Business Overview
  10.1.5 Novo Nordisk SWOT Analysis
  10.1.6 Novo Nordisk Recent Developments
10.2 Sanofi-Aventis
  10.2.1 Sanofi-Aventis Basic Information
  10.2.2 Sanofi-Aventis Self-injectable Biologics Product Overview
  10.2.3 Sanofi-Aventis Self-injectable Biologics Product Market Performance
  10.2.4 Sanofi-Aventis Business Overview
  10.2.5 Sanofi-Aventis SWOT Analysis
  10.2.6 Sanofi-Aventis Recent Developments
10.3 Eli Lilly
  10.3.1 Eli Lilly Basic Information
  10.3.2 Eli Lilly Self-injectable Biologics Product Overview
  10.3.3 Eli Lilly Self-injectable Biologics Product Market Performance
  10.3.4 Eli Lilly Business Overview
  10.3.5 Eli Lilly SWOT Analysis
  10.3.6 Eli Lilly Recent Developments
10.4 Tonghua Dongbao
  10.4.1 Tonghua Dongbao Basic Information
  10.4.2 Tonghua Dongbao Self-injectable Biologics Product Overview
  10.4.3 Tonghua Dongbao Self-injectable Biologics Product Market Performance
  10.4.4 Tonghua Dongbao Business Overview
  10.4.5 Tonghua Dongbao Recent Developments
10.5 United Laboratory
  10.5.1 United Laboratory Basic Information
  10.5.2 United Laboratory Self-injectable Biologics Product Overview
  10.5.3 United Laboratory Self-injectable Biologics Product Market Performance
  10.5.4 United Laboratory Business Overview
  10.5.5 United Laboratory Recent Developments
10.6 Biocon
  10.6.1 Biocon Basic Information
  10.6.2 Biocon Self-injectable Biologics Product Overview
  10.6.3 Biocon Self-injectable Biologics Product Market Performance
  10.6.4 Biocon Business Overview
  10.6.5 Biocon Recent Developments
10.7 GSK
  10.7.1 GSK Basic Information
  10.7.2 GSK Self-injectable Biologics Product Overview
  10.7.3 GSK Self-injectable Biologics Product Market Performance
  10.7.4 GSK Business Overview
  10.7.5 GSK Recent Developments
10.8 Bristol-Myers Squibb
  10.8.1 Bristol-Myers Squibb Basic Information
  10.8.2 Bristol-Myers Squibb Self-injectable Biologics Product Overview
  10.8.3 Bristol-Myers Squibb Self-injectable Biologics Product Market Performance
  10.8.4 Bristol-Myers Squibb Business Overview
  10.8.5 Bristol-Myers Squibb Recent Developments
10.9 Ganlee
  10.9.1 Ganlee Basic Information
  10.9.2 Ganlee Self-injectable Biologics Product Overview
  10.9.3 Ganlee Self-injectable Biologics Product Market Performance
  10.9.4 Ganlee Business Overview
  10.9.5 Ganlee Recent Developments
10.10 Julphar Diabetes
  10.10.1 Julphar Diabetes Basic Information
  10.10.2 Julphar Diabetes Self-injectable Biologics Product Overview
  10.10.3 Julphar Diabetes Self-injectable Biologics Product Market Performance
  10.10.4 Julphar Diabetes Business Overview
  10.10.5 Julphar Diabetes Recent Developments
10.11 Wockhardt
  10.11.1 Wockhardt Basic Information
  10.11.2 Wockhardt Self-injectable Biologics Product Overview
  10.11.3 Wockhardt Self-injectable Biologics Product Market Performance
  10.11.4 Wockhardt Business Overview
  10.11.5 Wockhardt Recent Developments
10.12 Viatris
  10.12.1 Viatris Basic Information
  10.12.2 Viatris Self-injectable Biologics Product Overview
  10.12.3 Viatris Self-injectable Biologics Product Market Performance
  10.12.4 Viatris Business Overview
  10.12.5 Viatris Recent Developments
10.13 BD
  10.13.1 BD Basic Information
  10.13.2 BD Self-injectable Biologics Product Overview
  10.13.3 BD Self-injectable Biologics Product Market Performance
  10.13.4 BD Business Overview
  10.13.5 BD Recent Developments
10.14 Johnson and Johnson
  10.14.1 Johnson and Johnson Basic Information
  10.14.2 Johnson and Johnson Self-injectable Biologics Product Overview
  10.14.3 Johnson and Johnson Self-injectable Biologics Product Market Performance
  10.14.4 Johnson and Johnson Business Overview
  10.14.5 Johnson and Johnson Recent Developments
10.15 Amgen
  10.15.1 Amgen Basic Information
  10.15.2 Amgen Self-injectable Biologics Product Overview
  10.15.3 Amgen Self-injectable Biologics Product Market Performance
  10.15.4 Amgen Business Overview
  10.15.5 Amgen Recent Developments
10.16 Biogen Idec
  10.16.1 Biogen Idec Basic Information
  10.16.2 Biogen Idec Self-injectable Biologics Product Overview
  10.16.3 Biogen Idec Self-injectable Biologics Product Market Performance
  10.16.4 Biogen Idec Business Overview
  10.16.5 Biogen Idec Recent Developments
10.17 Bayer
  10.17.1 Bayer Basic Information
  10.17.2 Bayer Self-injectable Biologics Product Overview
  10.17.3 Bayer Self-injectable Biologics Product Market Performance
  10.17.4 Bayer Business Overview
  10.17.5 Bayer Recent Developments
10.18 Pfizer
  10.18.1 Pfizer Basic Information
  10.18.2 Pfizer Self-injectable Biologics Product Overview
  10.18.3 Pfizer Self-injectable Biologics Product Market Performance
  10.18.4 Pfizer Business Overview
  10.18.5 Pfizer Recent Developments
10.19 Roche
  10.19.1 Roche Basic Information
  10.19.2 Roche Self-injectable Biologics Product Overview
  10.19.3 Roche Self-injectable Biologics Product Market Performance
  10.19.4 Roche Business Overview
  10.19.5 Roche Recent Developments
10.20 AbbVie
  10.20.1 AbbVie Basic Information
  10.20.2 AbbVie Self-injectable Biologics Product Overview
  10.20.3 AbbVie Self-injectable Biologics Product Market Performance
  10.20.4 AbbVie Business Overview
  10.20.5 AbbVie Recent Developments
10.21 Takeda Pharmaceutical
  10.21.1 Takeda Pharmaceutical Basic Information
  10.21.2 Takeda Pharmaceutical Self-injectable Biologics Product Overview
  10.21.3 Takeda Pharmaceutical Self-injectable Biologics Product Market Performance
  10.21.4 Takeda Pharmaceutical Business Overview
  10.21.5 Takeda Pharmaceutical Recent Developments

11 SELF-INJECTABLE BIOLOGICS MARKET FORECAST BY REGION

11.1 Global Self-injectable Biologics Market Size Forecast
11.2 Global Self-injectable Biologics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Self-injectable Biologics Market Size Forecast by Country
  11.2.3 Asia Pacific Self-injectable Biologics Market Size Forecast by Region
  11.2.4 South America Self-injectable Biologics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Self-injectable Biologics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Self-injectable Biologics Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Self-injectable Biologics by Type (2026-2035)
  12.1.2 Global Self-injectable Biologics Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Self-injectable Biologics by Type (2026-2035)
12.2 Global Self-injectable Biologics Market Forecast by Application (2026-2035)
  12.2.1 Global Self-injectable Biologics Sales (K Units) Forecast by Application
  12.2.2 Global Self-injectable Biologics Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Self-injectable Biologics Market Size by Type (M USD)
Table 4. Global Self-injectable Biologics Market Size by Application
Table 5. Self-injectable Biologics Market Size Comparison by Region (M USD)
Table 6. Global Self-injectable Biologics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Self-injectable Biologics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Self-injectable Biologics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Self-injectable Biologics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-injectable Biologics as of 2025)
Table 11. Global Market Self-injectable Biologics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Self-injectable Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Self-injectable Biologics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Self-injectable Biologics Sales by Type (K Units)
Table 27. Global Self-injectable Biologics Market Size by Type (M USD)
Table 28. Global Self-injectable Biologics Sales (K Units) by Type (2020-2025)
Table 29. Global Self-injectable Biologics Sales Market Share by Type (2020-2025)
Table 30. Global Self-injectable Biologics Market Size (M USD) by Type (2020-2025)
Table 31. Global Self-injectable Biologics Market Share by Type (2020-2025)
Table 32. Global Self-injectable Biologics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Self-injectable Biologics Sales (K Units) by Application
Table 34. Global Self-injectable Biologics Market Size by Application
Table 35. Global Self-injectable Biologics Sales by Application (2020-2025) & (K Units)
Table 36. Global Self-injectable Biologics Sales Market Share by Application (2020-2025)
Table 37. Global Self-injectable Biologics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Self-injectable Biologics Market Share by Application (2020-2025)
Table 39. Global Self-injectable Biologics Sales Growth Rate by Application (2020-2025)
Table 40. Global Self-injectable Biologics Sales by Region (2020-2025) & (K Units)
Table 41. Global Self-injectable Biologics Sales Market Share by Region (2020-2025)
Table 42. Global Self-injectable Biologics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Self-injectable Biologics Market Size by Region (2020-2025)
Table 44. North America Self-injectable Biologics Sales by Country (2020-2025) & (K Units)
Table 45. North America Self-injectable Biologics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Self-injectable Biologics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Self-injectable Biologics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Self-injectable Biologics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Self-injectable Biologics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Self-injectable Biologics Sales by Country (2020-2025) & (K Units)
Table 51. South America Self-injectable Biologics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Self-injectable Biologics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Self-injectable Biologics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Self-injectable Biologics Production (K Units) by Region(2020-2025)
Table 55. Global Self-injectable Biologics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Self-injectable Biologics Revenue Market Share by Region (2020-2025)
Table 57. Global Self-injectable Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Self-injectable Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Self-injectable Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Self-injectable Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Self-injectable Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk Self-injectable Biologics Product Overview
Table 64. Novo Nordisk Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Sanofi-Aventis Basic Information
Table 69. Sanofi-Aventis Self-injectable Biologics Product Overview
Table 70. Sanofi-Aventis Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Sanofi-Aventis Business Overview
Table 72. Sanofi-Aventis SWOT Analysis
Table 73. Sanofi-Aventis Recent Developments
Table 74. Eli Lilly Basic Information
Table 75. Eli Lilly Self-injectable Biologics Product Overview
Table 76. Eli Lilly Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly SWOT Analysis
Table 79. Eli Lilly Recent Developments
Table 80. Tonghua Dongbao Basic Information
Table 81. Tonghua Dongbao Self-injectable Biologics Product Overview
Table 82. Tonghua Dongbao Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Tonghua Dongbao Business Overview
Table 84. Tonghua Dongbao Recent Developments
Table 85. United Laboratory Basic Information
Table 86. United Laboratory Self-injectable Biologics Product Overview
Table 87. United Laboratory Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. United Laboratory Business Overview
Table 89. United Laboratory Recent Developments
Table 90. Biocon Basic Information
Table 91. Biocon Self-injectable Biologics Product Overview
Table 92. Biocon Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biocon Business Overview
Table 94. Biocon Recent Developments
Table 95. GSK Basic Information
Table 96. GSK Self-injectable Biologics Product Overview
Table 97. GSK Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. GSK Business Overview
Table 99. GSK Recent Developments
Table 100. Bristol-Myers Squibb Basic Information
Table 101. Bristol-Myers Squibb Self-injectable Biologics Product Overview
Table 102. Bristol-Myers Squibb Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Recent Developments
Table 105. Ganlee Basic Information
Table 106. Ganlee Self-injectable Biologics Product Overview
Table 107. Ganlee Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Ganlee Business Overview
Table 109. Ganlee Recent Developments
Table 110. Julphar Diabetes Basic Information
Table 111. Julphar Diabetes Self-injectable Biologics Product Overview
Table 112. Julphar Diabetes Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Julphar Diabetes Business Overview
Table 114. Julphar Diabetes Recent Developments
Table 115. Wockhardt Basic Information
Table 116. Wockhardt Self-injectable Biologics Product Overview
Table 117. Wockhardt Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Wockhardt Business Overview
Table 119. Wockhardt Recent Developments
Table 120. Viatris Basic Information
Table 121. Viatris Self-injectable Biologics Product Overview
Table 122. Viatris Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Viatris Business Overview
Table 124. Viatris Recent Developments
Table 125. BD Basic Information
Table 126. BD Self-injectable Biologics Product Overview
Table 127. BD Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. BD Business Overview
Table 129. BD Recent Developments
Table 130. Johnson and Johnson Basic Information
Table 131. Johnson and Johnson Self-injectable Biologics Product Overview
Table 132. Johnson and Johnson Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Johnson and Johnson Business Overview
Table 134. Johnson and Johnson Recent Developments
Table 135. Amgen Basic Information
Table 136. Amgen Self-injectable Biologics Product Overview
Table 137. Amgen Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Amgen Business Overview
Table 139. Amgen Recent Developments
Table 140. Biogen Idec Basic Information
Table 141. Biogen Idec Self-injectable Biologics Product Overview
Table 142. Biogen Idec Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Biogen Idec Business Overview
Table 144. Biogen Idec Recent Developments
Table 145. Bayer Basic Information
Table 146. Bayer Self-injectable Biologics Product Overview
Table 147. Bayer Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Bayer Business Overview
Table 149. Bayer Recent Developments
Table 150. Pfizer Basic Information
Table 151. Pfizer Self-injectable Biologics Product Overview
Table 152. Pfizer Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Pfizer Business Overview
Table 154. Pfizer Recent Developments
Table 155. Roche Basic Information
Table 156. Roche Self-injectable Biologics Product Overview
Table 157. Roche Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Roche Business Overview
Table 159. Roche Recent Developments
Table 160. AbbVie Basic Information
Table 161. AbbVie Self-injectable Biologics Product Overview
Table 162. AbbVie Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. AbbVie Business Overview
Table 164. AbbVie Recent Developments
Table 165. Takeda Pharmaceutical Basic Information
Table 166. Takeda Pharmaceutical Self-injectable Biologics Product Overview
Table 167. Takeda Pharmaceutical Self-injectable Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Takeda Pharmaceutical Business Overview
Table 169. Takeda Pharmaceutical Recent Developments
Table 170. Global Self-injectable Biologics Sales Forecast by Region (2026-2035) & (K Units)
Table 171. Global Self-injectable Biologics Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Self-injectable Biologics Sales Forecast by Country (2026-2035) & (K Units)
Table 173. North America Self-injectable Biologics Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Self-injectable Biologics Sales Forecast by Country (2026-2035) & (K Units)
Table 175. Europe Self-injectable Biologics Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Self-injectable Biologics Sales Forecast by Region (2026-2035) & (K Units)
Table 177. Asia Pacific Self-injectable Biologics Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Self-injectable Biologics Sales Forecast by Country (2026-2035) & (K Units)
Table 179. South America Self-injectable Biologics Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Self-injectable Biologics Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Self-injectable Biologics Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Self-injectable Biologics Sales Forecast by Type (2026-2035) & (K Units)
Table 183. Global Self-injectable Biologics Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Self-injectable Biologics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 185. Global Self-injectable Biologics Sales (K Units) Forecast by Application (2026-2035)
Table 186. Global Self-injectable Biologics Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Self-injectable Biologics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Self-injectable Biologics Market Size (M USD), 2025-2035
Figure 5. Global Self-injectable Biologics Market Size (M USD) (2020-2035)
Figure 6. Global Self-injectable Biologics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Self-injectable Biologics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Self-injectable Biologics Product Life Cycle
Figure 13. Self-injectable Biologics Sales Share by Manufacturers in 2025
Figure 14. Global Self-injectable Biologics Revenue Share by Manufacturers in 2025
Figure 15. Self-injectable Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Self-injectable Biologics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Self-injectable Biologics Revenue in 2025
Figure 18. Industry Chain Map of Self-injectable Biologics
Figure 19. Global Self-injectable Biologics Market PEST Analysis
Figure 20. Global Self-injectable Biologics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Self-injectable Biologics Market Share by Type
Figure 27. Sales Market Share of Self-injectable Biologics by Type (2020-2025)
Figure 28. Sales Market Share of Self-injectable Biologics by Type in 2025
Figure 29. Market Share of Self-injectable Biologics by Type (2020-2025)
Figure 30. Market Share of Self-injectable Biologics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Self-injectable Biologics Market Share by Application
Figure 33. Global Self-injectable Biologics Sales Market Share by Application (2020-2025)
Figure 34. Global Self-injectable Biologics Sales Market Share by Application in 2025
Figure 35. Global Self-injectable Biologics Market Share by Application (2020-2025)
Figure 36. Global Self-injectable Biologics Market Share by Application in 2025
Figure 37. Global Self-injectable Biologics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Self-injectable Biologics Sales Market Share by Region (2020-2025)
Figure 39. Global Self-injectable Biologics Market Size by Region (2020-2025)
Figure 40. North America Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Self-injectable Biologics Sales Market Share by Country in 2024
Figure 43. North America Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Self-injectable Biologics Market Size by Country in 2024
Figure 45. U.S. Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Self-injectable Biologics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Self-injectable Biologics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Self-injectable Biologics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Self-injectable Biologics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Self-injectable Biologics Sales Market Share by Country in 2024
Figure 53. Europe Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Self-injectable Biologics Market Size by Country in 2024
Figure 55. Germany Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Self-injectable Biologics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Self-injectable Biologics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Self-injectable Biologics Market Size by Region in 2024
Figure 68. China Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Self-injectable Biologics Sales and Growth Rate (K Units)
Figure 79. South America Self-injectable Biologics Sales Market Share by Country in 2024
Figure 80. South America Self-injectable Biologics Market Size and Growth Rate (M USD)
Figure 81. South America Self-injectable Biologics Market Size by Country in 2024
Figure 82. Brazil Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Self-injectable Biologics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Self-injectable Biologics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Self-injectable Biologics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Self-injectable Biologics Market Size by Region in 2024
Figure 92. Saudi Arabia Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Self-injectable Biologics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Self-injectable Biologics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Self-injectable Biologics Production Market Share by Region (2020-2025)
Figure 103. North America Self-injectable Biologics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Self-injectable Biologics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Self-injectable Biologics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Self-injectable Biologics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Self-injectable Biologics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Self-injectable Biologics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Self-injectable Biologics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Self-injectable Biologics Market Share Forecast by Type (2026-2035)
Figure 111. Global Self-injectable Biologics Sales Forecast by Application (2026-2035)
Figure 112. Global Self-injectable Biologics Market Share Forecast by Application (2026-2035)